Epidemiologic Study Evaluating Infections in Elderly Patients

Infection Clinical Trial

Official title:

Epidemiologic Study of Infections in Elderly Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00900952
• Other study ID #: 3074X1-4489
• Status: Completed
• Phase: N/A
• First received: May 7, 2009
• Last updated: October 8, 2009
• Start date: March 2009
• Est. completion date: June 2009

Study information

• Verified date: October 2009
• Source: Wyeth is now a wholly owned subsidiary of Pfizer
• Contact: n/a
• Is FDA regulated: No
• Health authority: Spain: Comité Ético de Investigación Clínica
• Study type: Observational

Clinical Trial Summary

The purpose of this observational study is to assess the prevalence and demographic and clinical characteristics of infections in elderly people admitted to Internal Medicine wards in Spain, as well as the etiology and resistance pattern for the main causal agents, and outcome.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 240
• Est. completion date: June 2009
• Est. primary completion date: June 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 65 Years and older

Eligibility

Inclusion criteria:

• Patients > 65 years of age that are hospitalized in an Internal Medicine ward and have an active infection (skin and soft tissue, intra-abdominal, or respiratory infections) from the community that needs antibiotic treatment

• Patients must have at least one sample processed for microbiological diagnosis

Exclusion criteria:

• COPD exacerbation

• Urinary tract infections

• Hospital acquired infections

• Other infections not in inclusion criteria

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Infection

Intervention

Other:
• Clinical record review

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Wyeth is now a wholly owned subsidiary of Pfizer

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Prevalence of each kind of infection will be measured from a descriptive point of view, using relative and absolute frequencies.		5 months	No
Secondary	Study the etiology and resistance pattern for the main causal agents.		5 months	No
Secondary	Describe the demographic features, co-morbidities, concomitant treatment and outcome of patients.		5 months	No